Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Randal W. Scott,PhDN/A1,185,1173.55%2012-07-10
Steven Shak,M.D.Chief Scientific Officer327,2070.98%2016-09-13
Joffre B. Baker,PhDN/A132,8460.4%2012-02-15
Dr. Fred E. Cohen,M.D.,D.Phil.N/A64,8930.19%2016-07-01
Kimberly J. PopovitsN/A58,7960.18%2016-02-15
G. Bradley ColeCOO35,4260.11%2016-09-06
Mr. James J. VaughnChief Commercial Officer29,079less than 0.1%2016-08-08
Mr. Frederic PlaN/A25,618less than 0.1%2016-02-15
Mr. Dean L. SchornoN/A24,524less than 0.1%2014-06-10
Brook H. ByersN/A23,951less than 0.1%2010-12-09

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Shak StevenChief Scientific Officer2016-09-13Sell5,000327,207$26.83134.157.49327,207 (Direct)
Cole G BradleyCOO2016-09-06Sell4,00035,426$27.41109.645.2235,426 (Direct)
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.25.87327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.0227026.74
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.35-0.135,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.220.3529,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.15.18327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.28.2635,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.8511.91327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.18.3435,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.92332,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.61384.4934,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.016.0315,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$2856331,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.313.41326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.08324,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-10.276,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-8.9927,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-14.2424,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.04-1.4427,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.19-1.6712,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.66-1.6724,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.1210.830,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.9813.7730,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.124.7630,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.969.9130,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.164.7229,658 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2015-04-13Sell3,000203,001$31.2893.84-7.8Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-5.2629,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-9.62Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-9.4229,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-3.42Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-8.0721,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-9.686,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-13.81Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-12.58Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-11.3221,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-17.17Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-18.4222,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-20.426,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-6.3Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.080.2422,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-3.29Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-4.1522,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.25.41312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.2110.63Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.778.46Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.226.6222,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$271896.81312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.117.89312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.310.5Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.484.4224,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.785.6822,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.628.67Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.3614.9523,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.759.87311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$27816.8122,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.521.69311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.283.8922,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.583.4415,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.665.33311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$27816.8124,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-8.47308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-3.87Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.512.3818,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-2.47308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-6Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-13.2621,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-17.416,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-16.6Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-13.5521,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-8.0918,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-2.8308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-3.87Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-3.7118,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-14.5313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-15.94Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-11.3418,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-12.3421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-8.426,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-12.55318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-12.69Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-1321,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-1321,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-14.3219,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-18.37318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-16.67Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-14.717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-14.717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-13.4713,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-13.96323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-19.17Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-19.6217,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-20.24
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-20.9213,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-21.44
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-20.776,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-21.82
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-21.91
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-23.057,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-22.45327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-20.88
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-19.516,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-16.02
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-16.217,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-16.89Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-19.9317,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-19.8712,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-3.87Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.483.7812,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.430.9512,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.583.82
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.42.527,087 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.961.26
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.51.552,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.532.45
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.082.8914,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.540.246,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.5317,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.73.4414,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.73.97333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.953.78Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$2884317,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.683.596,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.127.49288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.267.2536,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.77.05338,768 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.525.56288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.25.87Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.13.7288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$2884317,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.550.7714,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-12.82Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-18.18343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-14.6517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-14.6211,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-17.1314,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-14.57348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-8.99Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-17.6214,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-18.072,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-17.58353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-16.94Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-5.4114,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-19.676,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-15.77358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-17.03Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-18.51Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-19.7814,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-13.26363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-13.55Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-13.55Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-14.01Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-15.113,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-14.67367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-10.6
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-12.6926,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-14.88
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-15.75Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-14.417,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-3.74
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-4.57Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.18-0.113,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.691.37
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.422.236,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.653.26372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.953.78Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.983.0718,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.80.87Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-4.7613,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-4.12377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-4.09Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-4.09Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-4.12377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-7.2119,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-7.12Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-3.6713,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-4.22
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-4.22
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-4.22
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-3.25
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-3.25
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-3.25
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.19-0.76
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.6-0.76
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.71-0.76
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.52851.19Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.382.78
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.82.78
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.12.78
1,419,381 (Through Partnership)
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.72.49382,849 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.65-1.7
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.85-1.8
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.34-1.8
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.710.2820,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.760.2820,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.249.41
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.099.41
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.139.41
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.610.16Link
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.610.16Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.188.9514,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.024.836,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.19.16Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.18.34Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.77.85382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$2828317,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.854.727,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.25.03Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.1510.8387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.85.68Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.480.877,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.632.56
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.724.27
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.162.56
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.3111.31
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.1611.18
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.7811.31
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.3510.63392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.984.08
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.664.08
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.535.45
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.195.91
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.485.91
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.85.87Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.527.65
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.58.427,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.7411.18
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.4911.18
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9417.81
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1630.626,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.832.54392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.626.33Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5529.277,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.238.59Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.230.627,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.125.28392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.818Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1514.177,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1514.177,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.99.046,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.054.45392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.25.411,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.73.977,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.66.34392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.9111.3118,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.812.261,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.1210.12
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.9210.12
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.6810.08
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.4510.167,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.615.49
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.065.45
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.35.45
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.7512.88392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.488.9119,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.28.18Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.8311.227,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.0810.75Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.913.63Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.9213.14Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.3213.9Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.211.09Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.557.17Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2517.96Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7921.23Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3218.73Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3218.73Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.412.57Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.3810.8Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.7815.08Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.1215.08Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.0814.31Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.4413.32Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.0612.26Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.712.26Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9223.3Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2123.3Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3523.94Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5128.12Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0828.12Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244429.91Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.236.36Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.236.36Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8736.94Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.632.72Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6530.32Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6826.99Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.228.41Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.627.39Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514064.8Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.159.87Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.457.85Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.95279106.74Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7890.99Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.493.95Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5392.14Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1594.73Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9294.73Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.6499.45Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.1399.45Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.07100.7Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.73100.7Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.8198.62Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.398.62Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9492.39Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6192.39Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5691.37Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4294.21Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7694.21Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.592.27Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.296.06Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.5897.4Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.2397.4Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.2895.53Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2125.14Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41121Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.15283103.82Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.04105.27Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2482.76Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6881.73Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.284.75Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.885.94Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.470.95Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.570.65Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1470.85Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538948.28Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338649.43Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4848.74Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3248.28Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7945.44Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1569.15Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7969.15Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.667.38Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7864.71Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5269.55Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9469.55Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3468.26Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2567.19Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8765.08Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.643.34Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9541.44Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8441.23Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8842.49Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7842.35Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.250.13Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3343.91Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8844.27Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5844.2Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2539.66Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.141.23Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9239.59Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179836.23Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6536.49Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6539.12Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0439.53Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1443.34Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8538.85Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7444.34Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2744.34Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6844.34Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9144.34Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6547.67Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010044.2Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4447.97Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8847.9Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.847.97Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8847.97Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0448.51Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1748.05Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1180.14
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1180.14
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6257.85
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8963.03
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199551.79
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9160.49
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6260.49
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8160.49
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4560.49
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.643.34
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5248.2
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7247.52
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.147.52
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4647.52
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8247.52
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2846.25
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.6413.23
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.9714.13
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.848.66
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5550.76
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.634.01
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3640
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3640
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.238.32
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8548.58
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0242.98
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1149.82
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1149.82
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.856.74
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9845.14
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9845.14
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.643.84
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.742.98
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3241.65
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.428.12
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3527.22
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4832.35
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6525.77
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0327.1
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0821.84
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460618.98
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1221.38
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125237.33
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1549.74
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20244.2
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0444.78
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7744.85
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4644.85
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0544.85
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2860.31
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522553.81
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.249.66
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6467.48
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0853.08
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.840.82
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1542.56
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2227.72
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1225.34
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1925.72
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.4812.92
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8927.27
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9324.85
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4131.09
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8425.01
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4424.26
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9243.06
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8445.36
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2846.47
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.446.4
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5947.37
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3753.73
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9244.85
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9948.35
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1636.17
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018851.71
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9250.52
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2964.24
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8976.72
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8776.72
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.176.72
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0976.72
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7773.84
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6673.84
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.973.84
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6273.84
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9586.06
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6186.06
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0286.06
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.686.06
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8486.06
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9586.06
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4473.53
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.576.82
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2466.99
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4368.07
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1557.77
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8757.77
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.357.77
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2857.77
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2657.77
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.257.17
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1559.43
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8859.43
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.459.34
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0959.43
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4159.43
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1658.64
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2646.92
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1455.56
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.255.56
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7355.56
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0455.56
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0455.56
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5758.03
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5658.03
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0458.03
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6758.03
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5558.03
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4459.16
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8152.03
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8533.64
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4533.64
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1733.64
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0733.64
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.731.27
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3840
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8840
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1340
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2640
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.72105.27Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.21105.27Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.17105.27Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79140.33Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21140.33Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK